Click on image to view larger version.

Figure 6 Risk-adjusted predicted three-year costs as compared with observed three-year costs of care for patients undergoing nuclear imaging by the extent of myocardial ischemia. After controlling for pretest clinical risk and cardiac outcomes, significant (p < 0.0001) cost savings could be realized by decreasing resource use in patients with none to minimal ischemia on their nuclear scan.